In hereditary hemorrhagic telangiectasia, regulation is disrupted due to mutations in the BMP-9/10 pathway, namely in the type I receptor ALK1 or the co-receptor endoglin. This evidence concerns the gene ENG and hereditary hemorrhagic telangiectasia.